These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13635221)

  • 1. Relative suitability of urokon 70 per cent and hypaque 90 per cent for use as aortographic contrast media.
    KILLEN DA; LANCE EM; OWENS G
    Surgery; 1959 Mar; 45(3):436-44. PubMed ID: 13635221
    [No Abstract]   [Full Text] [Related]  

  • 2. Complication of aortography; factors influencing renal function following aoriography with 70 per cent urokon.
    BEALL AC; CRAWFORD ES; COUVES CM; DEBAKEY ME; MOYER JH
    Surgery; 1958 Mar; 43(3):364-80. PubMed ID: 13647159
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of means to prevent spinal cord and renal damage incident to Urokon aortography.
    KILLEN DA; LANCE EM
    Surgery; 1962 Mar; 51():338-46. PubMed ID: 14455924
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes of renal oxygen availability during urokon and hypaque aortography.
    KILLEN DA; OWENS G
    Ann Surg; 1960 Dec; 152(6):957-62. PubMed ID: 13755957
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of diatrizoate (hypaque) in peripheral angiography and aortography.
    MASSELL TB; GREENSTONE SM; HERINGMAN EC
    J Am Med Assoc; 1957 Aug; 164(16):1749-52. PubMed ID: 13448931
    [No Abstract]   [Full Text] [Related]  

  • 6. Ninety per cent hypaque for rapid intravenous roentgenography; preliminary report.
    FINBY N; POKER N; EVANS JA
    Radiology; 1956 Aug; 67(2):244-6. PubMed ID: 13350522
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental evaluation of the toxicity of hypaque, urokon, and thorotrast incident to their use as aortographic contrast media.
    KILLEN DA; LANCE EM; OWENS G
    Surg Forum; 1958; 9():337-9. PubMed ID: 13635385
    [No Abstract]   [Full Text] [Related]  

  • 8. [Selective renal arteriography: histological modifications induced by intra-arterial injection of contrast medium (hypaque) into the rabbit kidney].
    FRANCH L; PISANI E
    Arch Ital Urol; 1961 Apr; 34():107-23. PubMed ID: 13701207
    [No Abstract]   [Full Text] [Related]  

  • 9. Renai function after aortography with large contrast medium doses: an experimental study in dogs.
    EDLING NP; HELANDER CG; PERSSON F; ASHEIM A
    Acta radiol; 1958 Oct; 50(4):351-60. PubMed ID: 13605873
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrocardiographic alterations observed during percutaneous cerebral angiography; iodopyracet (diodrast) and diatrizoate (hypaque).
    EPSTEIN JA; HOFFMAN I; EPSTEIN BS
    AMA Arch Neurol Psychiatry; 1959 Feb; 81(2):142-7. PubMed ID: 13616770
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in cerebral circulation during carotid angiography with sod acetrizoate (triurol) and sodium diatrizoate (hypaque): an experimental study.
    KAGSTROM E; LINDGREN P; TORNELL G
    Acta radiol; 1958; 50(1-2):151-9. PubMed ID: 13605849
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ionic and nonionic contrast media on bradyarrhythmia during coronary angiography: a comparison of Renografin-76, Hypaque-76, and Isovue-370.
    Piao ZE; Hwang MH; Murdock DK; Loeb HS; Scanlon PJ
    J Lab Clin Med; 1990 Jan; 115(1):122-7. PubMed ID: 2299252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFFECTS OF TRANSAORTIC CATHETER INJECTION OF RENOGRAFIN, UROKON, HYPAQUE AND MIOKON INTO THE SUPERIOR MESENTERIC ARTERIES OF DOGS.
    COOLEY RN; SCHREIBER MH; BROWN RW
    Angiology; 1964 Mar; 15():107-13. PubMed ID: 14130377
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral angiographic contrast media; a comparison of hypaque 45% and urografin 60% and an assessment of the relative clinical toxicity of urografin 60%, hypaque 45%, diaginol 25% and diodone 35% in carotid arteriography.
    BROADBRIDGE AT; LESLIE EV
    Br J Radiol; 1958 Oct; 31(370):556-60. PubMed ID: 13584747
    [No Abstract]   [Full Text] [Related]  

  • 15. TOXIC REACTIONS INCIDENT TO AORTOGRAPHY. THE HAZARD OF REPEAT INJECTION.
    RHEA WG; O'NEILL JA; KILLEN DA; FOSTER JH
    Circulation; 1964 Apr; 29():SUPPL:161-4. PubMed ID: 14150961
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kidney function after abdominal aortography using different tri-iodinated contrast media].
    Metys R; Hornych A; Buriánovà B
    Fortschr Geb Rontgenstr Nuklearmed; 1971 Aug; 115(2):201-6. PubMed ID: 5107308
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diatrizoate sodium (hypaque) as contrast medium in peripheral aortography & arteriography].
    SWIATLO MR; KITAINIK E
    Prensa Med Argent; 1958 Nov; 45(48):3748-50. PubMed ID: 13667813
    [No Abstract]   [Full Text] [Related]  

  • 18. Urographic media; a study of the relative merits of urografin 60 per cent and hypaque 45 per cent.
    CABLE R
    J Fac Radiol; 1959 Apr; 10(2):100-2. PubMed ID: 24545251
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of aortographic and coronarographic examinations on the central nervous system].
    Szlávy L
    Radiol Diagn (Berl); 1968; 9(2):158. PubMed ID: 5682691
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of the value of sodium acetrizoate (diaginol) 50 per cent and sodium diatrizoate (hypaque) 45 per cent in intravenous urography.
    GREEN B; SOWERBUTTS JG
    Br J Radiol; 1956 Mar; 29(339):161-5. PubMed ID: 13304289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.